In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Management of bleeding and other emergent situations in patients on NOACS in the acute setting - The role of antidotes

ACCA webinar

08/03/2017 18:00 08/03/2017 19:00 Europe/Paris Management of bleeding and other emergent situations in patients on NOACS in the acute setting - The role of antidotes

Access event page

Association for Acute CardioVascular Care contact@escardio.org DD/MM/YYYY
Acute Cardiac Care
Anticoagulants
Acute Coronary Syndromes
Online
event

Focus on

Learning Objectives :

By attending this Webinar you will learn:

  • The appropriate management of patients on NOACs that require an urgent or emergent invasive intervention or that present with bleeding complications.
  • The usefulness and limitations of coagulation tests to guide management decisions in this setting.
  • The indications and effects of non-specific reversal therapies.
  • The pharmacology, effects and appropriate clinical use of the first approved NOAC antidote idarucizumab.
  • The principles and available evidence on the newer reversal agents.